Skip to content
EntityQ75175937· pop 8· linked from 483 articles

Also known as AMG510, AMG-510, AMG 510

Sotorasib, sold under the brand names Lumakras and Lumykras, is an anti-cancer medication used to treat non-small-cell lung cancer. It targets a specific mutation, G12C, in the protein K-Ras encoded by gene KRAS which is responsible for various forms of cancer. Sotorasib is an inhibitor of the RAS GTPase family.

Wikidata facts

Mass
560.2347452600001
Show 4 more facts
isomeric SMILES
CC(C)c1nccc(C)c1N2C(=O)N=C(N3CCN(C[C@@H]3C)C(=O)C=C)c4cc(F)c(nc24)c5c(O)cccc5F
chemical formula
C₃₀H₃₀F₂N₆O₃
Commons category
Sotorasib
canonical SMILES
CC1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C
Sources (3)

via Wikidata · CC0

~7 min read

Encyclopedic overview

11 sections
Contents
  • Medical uses
  • Chemistry and pharmacology
  • History
  • Society and culture
  • Economics
  • Legal status
  • Names
  • Research
  • References
  • Further reading
  • External links

Sotorasib, sold under the brand names Lumakras and Lumykras, is an anti-cancer medication used to treat non-small-cell lung cancer. It targets a specific mutation, G12C, in the protein K-Ras encoded by gene KRAS which is responsible for various forms of cancer. Sotorasib is an inhibitor of the RAS GTPase family.

The most common side effects include diarrhea, musculoskeletal pain, nausea, fatigue, liver damage and cough. The most common adverse reactions for sotorasib used in combination with panitumumab include rash, dry skin, diarrhea, stomatitis, fatigue, and musculoskeletal pain.

Excerpted from Wikipedia’s “sotorasib” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0